首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

BLOOD REVIEWS
ISSN：0268-960X

BLOOD REVIEWS

BLOOD REV
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：约稿?周期不定
新锐分区：医学2区
年发文量：58
影响因子：5.7
JCR分区：Q1

基本信息

这本受人尊敬的国际期刊《血液评论》是一个重要的信息资源，汇集了公认专家对临床实践和研究的评价。由领先的研究人员和从业者特别委托撰写的文章保证了真正的全球覆盖血液学的所有子专业。Blood Reviews发表涵盖临床和实验室血液学实践和研究的综述文章。虽然大多数评论都是邀请来的，但编辑们欢迎潜在作者的建议。他们应该首先写一个简短的大纲，打算审查，并发送给特雷弗巴格林博士或雅各布M罗博士。
0268-960XSCIE/Scopus收录
5.7
点击查看最新影响趋势>
6.9
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学2区
HEMATOLOGY 血液学
2区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：HEMATOLOGY
SCIE
Q1
14/99
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：HEMATOLOGY
SCIE
Q1
15/100
85
58
点击查看年发文量趋势图>
1%较难约稿?周期不定-医学-血液学
0%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
0.00%26.5%-
CiteScore：15.00
SJR：2.283
SNIP：2.110
学科类别分区排名百分位
大类：Medicine
小类：Hematology
Q1
10 / 142
大类：Medicine
小类：Oncology
Q1
32 / 415

期刊高被引文献

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100648
Genotype-phenotype associations in Fanconi anemia: A literature review.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100589
Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.09.001
Cellular therapy for acute myeloid Leukemia - Current status and future prospects.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.05.002
CAR-T - and a side order of IgG, to go? - Immunoglobulin replacement in patients receiving CAR-T cell therapy.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100596
The emerging role of exosomes in multiple myeloma.
来源期刊：Blood reviewsDOI：10.1016/J.BLRE.2019.100595
Challenges of blood transfusions in β-thalassemia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100588
The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.11.003
Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor.
来源期刊：Blood reviewsDOI：10.1016/J.BLRE.2019.04.001
New developments in diagnosis, risk assessment and management in systemic amyloidosis.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100636
Atrial fibrillation and cancer - An unexplored field in cardiovascular oncology.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.03.005
Prognostic and therapeutic role of CLEC12A in acute myeloid leukemia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.10.003
Rationale for assessing the therapeutic potential of resveratrol in hematological malignancies.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.07.001
Hypertension in hematologic malignancies and hematopoietic cell transplantation: An emerging issue with the introduction of novel treatments.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.03.003
Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100592
Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.04.003
Allogeneic hematopoietic cell transplantation; the current renaissance.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.11.001
Current and evolving understanding of atypical chronic myeloid leukemia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.07.004
Management of the aging beta-thalassemia transfusion-dependent population - The Italian experience.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100594
Venous thromboembolism incidence in hematologic malignancies.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.06.002
Extramedullary disease in multiple myeloma - controversies and future directions.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.04.002
Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100640
Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.05.003
Review of current transfusion therapy and blood banking practices.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100593
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100635
The golden age for patients in their golden years: The progressive upheaval of age and the treatment of newly-diagnosed acute myeloid leukemia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100639
Cellular immunotherapy for acute myeloid leukemia: How specific should it be?
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.02.001
Why do myeloma patients have bone disease? A historical perspective.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100646
Modelling human haemoglobin switching.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.06.001
From multi-target anticoagulants to DOACs, and intrinsic coagulation factor inhibitors.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100615
Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100637
The central role of thrombin in bleeding disorders.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.05.006
Use of novel therapies in the treatment of light chain amyloidosis.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.05.005
Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.01.001
Recent landmark studies in follicular lymphoma.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.03.006
Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100641
Paradigm shift for the treatment of hereditary haemophilia: Towards precision medicine.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100618
Blood doping: Then and now. A narrative review of the history, science and efficacy of blood doping in elite sport.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100632
The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100643
The gut microbiota in transplant patients.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100614
Management of bleeding and procedures in patients on antiplatelet therapy.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100619
Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease: A systematic review.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100633
Radiosynovectomy in haemophilia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.01.002
Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.04.004
Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100645
Too much iron: A masked foe for leukemias.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100617
Therapy-related acute lymphoblastic leukemia: Where do we stand with regards to its definition and characterization?
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.06.001
Impact of transfusion on survival in patients with myelodysplastic syndromes: Current knowledge, new insights and transfusion clinical practice.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100649
Thrombocytopenia in pregnancy: Diagnosis and approach to management.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100638
The emerging role of red blood cells in cytokine signalling and modulating immune cells.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100644

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACADEMIC EMERGENCY MEDICINE封面

ACADEMIC EMERGENCY MEDICINE

学科领域：医学
影响因子：3.2
中科院分区： 2区
ACADEMIC RADIOLOGY封面

ACADEMIC RADIOLOGY

学科领域：医学
影响因子：3.9
中科院分区： 2区
APPETITE封面

APPETITE

学科领域：医学
影响因子：3.8
中科院分区： 2区
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA封面

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

学科领域：医学
影响因子：3.1
中科院分区： 2区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学2区
HEMATOLOGY 血液学
2区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学2区
HEMATOLOGY 血液学
2区
否
是
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学2区
HEMATOLOGY 血液学
2区
否
是